CMO Insight with Victor Coker
Decreasing profits in pharmaceuticals over the past 5 years has put manufacturing and product costs under greater scrutiny. As a result there has been an increase in the need for a reduction in the size and cost of internal manufacturing and sourcing of cheaper products from external parties. As contract manufacturing in pharmaceuticals continues to increase, Victor Coker, Director of Business Intelligence for Nice Insight, speaks to Andrea Charles from Pharma IQ, about the meth...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.